Adamis Pharmaceuticals reported 0 in Interest Expense on Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Adamis Pharmaceuticals ADMP:US 0 0
Adma Biologics ADMA:US $ 3.39M 0.07M
Merk MRK:US $ 243M 34M
Pfizer PFE:US $ 322M 6M